TrialProceedings of the National Academy of Sciences of the United States of America2009

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

Grazia Galli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.